4579.T

RaQualia Pharma Inc · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$16.44B

PE Ratio

18.326656419045374

EV to Ebitda

—

Earnings Yield

5.46%

Revenue (TTM)

$22.8M

Net Income (TTM)

$7.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

50.80%

Profit Margin

34.45%

Return on Equity

—

Debt to Equity Ratio

0.0023721733110392885

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$16.44B

Revenue TTM$22.8M

Shares Outstanding21.6M

Float18244119

Insider Ownership18.78%

Institutional Ownership7.71%

Growth Estimates8 fields›

Revenue Growth (Quarterly YoY)50.80%

Rev Growth Est 1Y Forward0.2080

EPS Growth (Quarterly YoY)416.20%

EPS Growth Est Quarterly0

LT EPS Growth Estimates166.20%

EBITDA Growth (Quarterly YoY)-123.89%

CFO Growth (Quarterly YoY)77.47%

FCF Growth (Quarterly YoY)89.54%

Operations22 fields›

Revenue TTM$22.8M

Gross Margin TTM90.81%

Gross Margin (Quarterly)86.14%

Operating Margin TTM36.02%

Operating Margin (Quarterly)-10.98%

Operating Expenses TTM$0.04M

Profit Margin TTM34.45%

Profit Margin (Quarterly)-0.73%

Net Income TTM$7.8M

EPS TTM50.08

EPS (Quarterly)-0.15512380740761314

EBIT Margin TTM40.79%

EBITDA Margin TTM40.79%

EBITDA Margin (Quarterly)8.12%

EBITDA TTM$9.3M

CFO % of Revenue TTM24.77%

CFO % of Revenue (Quarterly)75.02%

CFO TTM$5.6M

Capex % of Revenue TTM1.58%

Capital Expenditures$0.36M

FCF % of Revenue (Quarterly)8.52%

FCF TTM$5.4M

Efficiency1 fields›

ROA13.30%

Valuation11 fields›

P/E (TTM)18.326656419045374

P/E Forward0

P/CFO25.47471264367816

P/FCF26.77761641747744

EV/Revenues (TTM)8.3669

Price To Book3.677044986851546

Price to Tangible Book3.677044986851546

Earnings Yield5.46%

FCF Yield3.73%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity11 fields›

Cash Per Share24.73915672738775

Current Ratio9.996342291598006

Total Debt$250.6M

Total Assets$43.6M

Total Liabilities$16.8M

Shareholders Equity$39.1M

Debt to Equity0.0023721733110392885

Debt to Assets4.28%

Interest Expense$0.04M

CFO to Debt (TTM)3.021691593111044

Debt to EBITDA (TTM)26.952288397568527

Yields4 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield5.46%

Buyback Yield284.28%